» Authors » Ana Gradissimo

Ana Gradissimo

Explore the profile of Ana Gradissimo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 297
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fei T, Donovan V, Funnell T, Baichoo M, Waters N, Paredes J, et al.
bioRxiv . 2025 Mar; PMID: 40027751
Correlating time-dependent patient characteristics and matched microbiome samples can be helpful to identify biomarkers in longitudinal microbiome studies. Existing approaches typically repeat a pre-specified modeling approach for all taxonomic features,...
2.
Dai A, Adintori P, Funnell T, Jogia W, Fei T, Waters N, et al.
bioRxiv . 2024 Oct; PMID: 39463943
Intestinal microbiota composition is implicated in several diseases; understanding the factors that influence it are key to elucidating host-commensal interactions and to designing microbiome-targeted therapies. We quantified how diet influences...
3.
Usyk M, Schlecht N, Viswanathan S, Gradissimo A, Valizadegan N, Sollecito C, et al.
Int J Mol Sci . 2023 Jul; 24(14). PMID: 37511598
Trichomoniasis, caused by (TV), is the most common non-viral sexually transmitted infection (STI) worldwide, affecting over 174 million people annually and is frequently associated with reproductive co-morbidities. However, its detection...
4.
Gradissimo A, Clarke M, Xue X, Castle P, Raine-Bennett T, Schiffman M, et al.
J Natl Cancer Inst . 2023 Jul; 115(12):1535-1543. PMID: 37467068
Background: The widespread introduction of Pap testing in the 1960s was followed by substantial reductions in the incidence of cervical squamous cell cancer (SCC). However, the incidence of cervical adenocarcinoma...
5.
Nguyen C, Markey K, Miltiadous O, Dai A, Waters N, Sadeghi K, et al.
Cell . 2023 Jun; 186(12):2705-2718.e17. PMID: 37295406
Discerning the effect of pharmacological exposures on intestinal bacterial communities in cancer patients is challenging. Here, we deconvoluted the relationship between drug exposures and changes in microbial composition by developing...
6.
Usyk M, Schlecht N, Pickering S, Williams L, Sollecito C, Gradissimo A, et al.
Nat Commun . 2022 Jan; 13(1):233. PMID: 35017496
Bacterial vaginosis (BV) is a highly prevalent condition that is associated with adverse health outcomes. It has been proposed that BV's role as a pathogenic condition is mediated via bacteria-induced...
7.
Gradissimo A, Shankar V, Wiek F, St Peter L, Studentsov Y, Nucci-Sack A, et al.
Viruses . 2021 Aug; 13(8). PMID: 34452413
The goal of this study was to investigate the serological titers of circulating antibodies against human papillomavirus (HPV) type 16 (anti-HPV16) prior to the detection of an incident HPV16 or...
8.
Bee K, Gradissimo A, Chen Z, Harari A, Schiffman M, Raine-Bennett T, et al.
Int J Mol Sci . 2021 Jul; 22(12). PMID: 34208758
The goal of this study was to identify human papillomavirus (HPV) type 52 genetic and epigenetic changes associated with high-grade cervical precancer and cancer. Patients were selected from the HPV...
9.
Usyk M, Zolnik C, Castle P, Porras C, Herrero R, Gradissimo A, et al.
PLoS Pathog . 2020 Mar; 16(3):e1008376. PMID: 32214382
Background: Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections. However, only a small percentage of high-risk (HR) HPV infections progress to cervical precancer and cancer....
10.
Wang Z, Usyk M, Sollecito C, Qiu Y, Williams-Nguyen J, Hua S, et al.
Clin Infect Dis . 2019 Nov; 71(9):2345-2353. PMID: 31748797
Background: Alterations in gut microbiota (GMB) and host metabolites have been noted in individuals with HIV. However, it remains unclear whether alterations in GMB and related functional groups contribute to...